Ultimele actualizari :
16/01/2021
Infostab
Listele
Listele
Cauta incompatibilitile
Tabel de incompatibilitati
Bibliografie
Echipe de cercetare
Poster
Conexiuni
Autor
Mod de utilizare
Newsletter
Bibliografie 4433
Tip :
Ziar
Internet legătură într- :
https://doi.org/10.1016/j.clinthera.2020.01.017
Echipe de cercetare :
Philadelphie - Philadelphia College of Pharmacy and Science
Autor :
Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K.
Titlu :
Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications
Référence :
Clin Ther ; 42, 3: 475-485. 2020
Nivelul dovezii :
Stabilitatea fizică :
Stabilitate chimică :
Alte metode :
Comentarii :
Listele
Dexamethasone sodium phosphate
1 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Furosemide
10 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Haloperidol
5 mg
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Hydrocortisone sodium succinate
1 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Dexamethasone sodium phosphate
1 mg/ml
+
5 mg/ml
+
Furosemide
10 mg/ml
+
5 mg/ml
+
Haloperidol
5 mg
+
5 mg/ml
+
Hydrocortisone sodium succinate
1 mg/ml
+
5 mg/ml
+
Insulin glulisine
1 U/ml
+
5 mg/ml
+
Labetalol hydrochloride
2 mg/ml
+
5 mg/ml
+
Phenytoin sodium
5 mg/ml
+
Insulin glulisine
1 U/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Labetalol hydrochloride
2 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Phenytoin sodium
5 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Mentions Légales